Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Former Bristol Myers Squibb campus set up for ‘reshoring’

by Rick Mullin
June 26, 2020 | A version of this story appeared in Volume 98, Issue 25

 

A former Bristol Myers Squibb facility near Princeton, New Jersey, has been acquired by Lincoln Equities Group and H.I.G. Realty Partners. The real estate firms intend to market the 111,000 m2 manufacturing and research campus to drug and biotech firms seeking to establish US manufacturing of drugs and drug chemicals that are currently outsourced. The campus includes nine production, lab, and storage buildings. PTC Therapeutics operates a biologics production facility and research labs at the site.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.